Moorgreen Hospital was a community hospital in West End, near Southampton. It was managed by Southampton City Primary Care Trust.

There are 78 beds in Moorgreen Hospital; Memory Assessment & Rsch Ctr.

During the past decade, Moorgreen Hospital; Memory Assessment & Rsch Ctr conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moorgreen Hospital; Memory Assessment & Rsch Ctr" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "TauRx Therapeutics Ltd" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Hunter-Fleming Ltd" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moorgreen Hospital; Memory Assessment & Rsch Ctr" #1 collaborator was "Hampshire Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Moorgreen Hospital; Memory Assessment & Rsch Ctr" are "Alzheimer's Disease" (8 trials), "Behavioral Variant Frontotemporal Dementia" (1 trials) and "Dementia With Lewy Bodies" (1 trials). Many other conditions were trialed in "Moorgreen Hospital; Memory Assessment & Rsch Ctr" in a lesser frequency.

Most popular intervention types in "Moorgreen Hospital; Memory Assessment & Rsch Ctr" are "Drug" (8 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Crenezumab" (1 trials), "Etanercept" (1 trials), "Gantenerumab" (1 trials) and "HF0220" (1 trials). Other intervention names were less common.

The vast majority of trials in "Moorgreen Hospital; Memory Assessment & Rsch Ctr" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Moorgreen Hospital; Memory Assessment & Rsch Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Moorgreen Hospital; Memory Assessment & Rsch Ctr, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Moorgreen Hospital; Memory Assessment & Rsch Ctr, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".